Skip to main content
Clinical Trials/NL-OMON54106
NL-OMON54106
Recruiting
Phase 4

Gag Therapy for Recurrent urine tract infection Assessing Comparability to International Nitrofurantoin Gold standard study. - GT RACING

Radboud Universitair Medisch Centrum0 sites100 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Urinary tract infections
Sponsor
Radboud Universitair Medisch Centrum
Enrollment
100
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Adult female patients (\>18 years) who had at least 3 symptomatic UTI\*s in
  • the previous year with no adequate curable therapeutic options (e.g. bladder
  • 2\) All UTI\*s must be confirmed with a urine sediment with positive nitrite or
  • positive urine cultures.

Exclusion Criteria

  • Male, \< 18 yrs, pregnant, already on GAG therapy, Gentamycin bladder
  • instillations in the previous 2 months, allergic to Nitrofurantoin and
  • Trimethoprim, urologic conditions: fistula, stones, cancer, BPS\-IC, catheter,
  • STD or a urinary diversion. Performing self\-catheterisation \> 1/day, GFR \< 30,
  • Severe lung or kidney disfunction, not tolerate catherization

Outcomes

Primary Outcomes

Not specified

Similar Trials